Numinus Wellness, Inc. (NUMIF)
0.0207
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Numinus Wellness Enterprise Value : 7.475M for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 7.475M |
| October 07, 2026 | 6.921M |
| October 06, 2026 | 8.762M |
| October 05, 2026 | 6.888M |
| October 02, 2026 | 7.946M |
| October 01, 2026 | 6.792M |
| September 30, 2026 | 7.171M |
| September 29, 2026 | 6.921M |
| September 28, 2026 | 8.299M |
| September 25, 2026 | 7.241M |
| September 24, 2026 | 6.60M |
| September 23, 2026 | 8.587M |
| September 22, 2026 | 8.892M |
| September 21, 2026 | 8.924M |
| September 18, 2026 | 7.562M |
| September 17, 2026 | 8.363M |
| September 16, 2026 | 7.562M |
| September 15, 2026 | 7.850M |
| September 14, 2026 | 9.004M |
| September 11, 2026 | 10.41M |
| September 10, 2026 | 9.229M |
| September 09, 2026 | 9.132M |
| September 08, 2026 | 9.729M |
| September 04, 2026 | 11.65M |
| September 03, 2026 | 11.63M |
| Date | Value |
|---|---|
| September 02, 2026 | 11.78M |
| September 01, 2026 | 11.70M |
| August 31, 2026 | 11.47M |
| August 28, 2026 | 13.30M |
| August 27, 2026 | 13.62M |
| August 26, 2026 | 12.15M |
| August 25, 2026 | 12.63M |
| August 24, 2026 | 12.08M |
| August 21, 2026 | 13.65M |
| August 20, 2026 | 13.10M |
| August 19, 2026 | 12.43M |
| August 18, 2026 | 13.62M |
| August 17, 2026 | 12.66M |
| August 14, 2026 | 12.59M |
| August 13, 2026 | 10.54M |
| August 12, 2026 | 13.56M |
| August 11, 2026 | 15.03M |
| August 10, 2026 | 12.05M |
| August 07, 2026 | 12.17M |
| August 06, 2026 | 11.09M |
| August 05, 2026 | 10.51M |
| August 04, 2026 | 12.20M |
| August 03, 2026 | 12.05M |
| July 31, 2026 | 10.70M |
| July 30, 2026 | 11.15M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cocrystal Pharma, Inc. | 13.85M |
| Edesa Biotech, Inc. | 33.34M |
| CNBX Pharmaceuticals, Inc. | 1.453M |
| Invion Ltd. | -- |
| ProMIS Neurosciences, Inc. | 28.59M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.1881M |
| Revenue (Quarterly) | 1.171M |
| Total Expenses (Quarterly) | 1.359M |
| EPS Diluted (Quarterly) | -0.0007 |
| Gross Profit Margin (Quarterly) | 51.16% |
| Profit Margin (Quarterly) | -16.07% |
| Earnings Yield | 76.70% |
| Normalized Earnings Yield | 81.04 |